Initial experience with short-course corticosteroids in a small cohort of adults with severe COVID-19 in a tertiary care hospital in India
Jha, S.; Shetty, K.; Vadi, S.; Phadtare, S.; Raut, A.; Shah, S.; Bhargava, P.; Singhal, T.
Show abstract
Severe COVID 19 disease is associated with high morbidity and mortality with limited therapeutic options. The role of glucocorticoids in treatment of COVID 19 has been riddled with controversy. The study site has been using glucocorticoids in patients with severe COVID 19 since the first few patients of COVID 19 that were admitted. In the initial cohort of 7 patients with severe COVID disease, use of methylprednisolone in a dose of 30 mg twice daily was associated with rapid improvement in oxygenation and decline in CRP levels. While six patients made a complete clinical recovery, one patient died. There were no secondary infections.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Characteristics and outcome profile of Hospitalized African COVID-19 patients: The Ethiopian Context 95%
- COVID-19 Disease Severity and Determinants among Ethiopian Patients: A study of the Millennium COVID-19 Care Center 95%
- Prevalence, characteristics, and predictors of Long COVID among diagnosed cases of COVID-19 95%
Similar papers in this journal
- Clearing the fog: Is Hydroxychloroquine effective in reducing Corona virus disease-2019 progression: A randomized controlled trial 95%
- Comparison of Efficacy of Dexamethasone and Methylprednisolone in Improving the Partial Pressure of Arterial Oxygen and Fraction of Inspired Oxygen Ratio among COVID-19 Patients 94%
- Comparative study between first and second wave of COVID-19 deaths in India - a single center study 94%
Similar papers in this journal
- Relative expression of pro-inflammatory molecules in COVID-19 patients manifested disease severities 94%
- Risk factors for bacterial infections in patients with moderate to severe COVID-19: A case control study 93%
- A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying different outcome between gender. 93%
Similar papers in this journal
- Determinants of Developing Symptomatic Disease in Ethiopian COVID-19 Patients 95%
- Evaluation of the disease outcome in Covid-19 infected patients by disease symptoms: a retrospective cross-sectional study in Ilam Province, Iran 93%
- Prevalence of Common Respiratory Viruses in Children: Insights from Post-Pandemic Surveillance 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.